Five notes:
1. Second quarter revenue grew 25% year-over-year, and surgical sales grew 27%, according to a news release.
2. Alphatec saw 20% growth year-over-year in new surgeon adoption for its products and has 244 surgeon training engagements.
3. Alphatec deployed more than $50 million to capitalize on surgeon adoption and growing its U.S. footprint.
4. The company saw a $41 million net loss in the second quarter.
5. Alphatec’s full year guidance expects 2024 revenue to hit $602 million, up 25% compared to 2023.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
